Multigenerational familial medullary thyroid cancer (FMTC): Evidence for FMTC phenocopies and association with papillary thyroid cancer

Clinical Endocrinology

Volumn 56, Issue 1, 2002, Pages 53-63

  Fugazzola, L ^b   Cerutti, N ^c   Mannavola, D ^a   Ghilardi, G ^d   Alberti, L ^e   Romoli, R ^a   Beck Peccoz, P ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d Ospedale S Biagio   (Italy)

^e ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; DISEASE ASSOCIATION; EXON; FAMILIAL CANCER; FEMALE; GENE ACTIVATION; GENE LOCUS; GENE ORDER; GENE SEGREGATION; GENETIC ANALYSIS; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GERM LINE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; ONCOGENE RET; PAPILLARY CARCINOMA; PATHOGENESIS; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; SCHOOL CHILD; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CHILD; FEMALE; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; ITALY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, MULTIPLE PRIMARY; PEDIGREE; POINT MUTATION; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA; THYROID NEOPLASMS;

EID: 0036156121     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0300-0664.2001.01434.x     Document Type: Article

References (53)

1. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease
2. RET mutations in exons 13 and 14 of FMTC patients
3. Age-related activation of the tyrosine kinase receptor proto-oncogenes RET and NTRK1 in papillary thyroid carcinoma
4. Is screening for thyroid carcinoma indicated in familial adenomatous polyposis?
5. Two families with an autosomal dominant inheritance pattern for papillary carcinoma of the thyroid
6. Phenotype and phenocopy: The relationship between genotype and clinical phenotype in single large family with multiple endocrine neoplasia type 1 (MEN 1)
7. Association of thyroid carcinoma with Gardner's syndrome in siblings
8. DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the ret proto-oncogene
9. The ret/PTC1 oncogene is activated in familial adenomatous polyposis-associated thyroid papillary carcinomas
10. Cowden's diseases: A case report and literature review
11. A codon 891 exon 15 RET proto-oncogene mutation in familial medullary thyroid carcinoma: A detection strategy
12. Expression of papillary thyroid carcinoma in multiple endocrine neoplasia type 2A
13. Mutation in the RET proto-oncogene are associated with MEN 2A and FMTC
14. Familial papillary thyroid cancer: Many syndromes, too many genes?
15. Will the real Cowden syndrome please stand up: Revised diagnostic criteria
16. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and Hirschsprung disease
17. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2
18. Editorial: Familial non-medullary thyroid carcinoma: The case for genetic susceptibility
19. The impact of gene mapping techniques on the management of multiple endocrine neoplasia type 2
20. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis
21. Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation
22. A large multiple endocrine neoplasia type 1 family with clinical expression suggestive of anticipation
23. Familial papillary carcinoma of the thyroid
24. Identification and characterization of the familial adenomatous polyposis coli gene
25. Familial non-medullary thyroid cancer: An emerging entity that warrants aggressive treatment
26. Clinical features of multiple endocrine neoplasia type I (MEN I) phenocopy without germline MEN I gene mutations: Analysis of 20 Japanese sporadic cases with MEN I
27. A novel point mutation in the intracellular domain of the ret proto-oncogene in a family with medullary thyroid carcinoma
28. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma
29. High prevalence of RET rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident
30. Genetic analyses of a family with familial medullary and papillary thyroid carcinoma
31. Phenocopies for deafness and goiter development in a large inbread Brazialian kindred with Pendred's syndrome associated with a novel mutation in the PDS gene
32. Familial papillary carcinoma of the thyroid
33. Genetic heterogeneity in familial non-medullary thyroid carcinoma: Exclusion of linkage to RET, MNG1, and TCO in 56 families
34. Familial non-medullary thyroid carcinoma: A meta-review of case series
35. Familial occurrence of papillary thyroid carcinoma
36. At least three genes account for familial papillary thyroid carcinoma: TCO and MNG1 excluded as susceptibility loci from a large Tasmanian family
37. Papillary thyroid carcinoma associated with papillary renal neoplasia: Genetic linkage analysis of a distinct heritable tumor syndrome
38. Familial papillary thyroid carcinoma is genetically distinct from familial adenomatous polyposis coli
39. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma
40. Papillary microcarcinoma of the thyroid: A clinico-pathologic and prognostic review
41. Familial occurrence of differentiated non-medullary thyroid carcinoma
42. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2
43. Induction of specific phosphodiesterase isoforms by constitutive activation of the cAMP pathway in autonomous thyroid adenomas
44. Age of onset in familial adenomatous polyposis: Heterogeneity within families and among APC mutations
45. Molecular diagnosis of residual and recurrent thyroid cancer by amplificatio of thyroglobulin messenger ribonucleic acid in peripheral blood
46. Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: An unusual presentation of multiple endocrine neoplasia type 2A?
47. Molecular defects in thyroid carcinomas: Role of the RET oncogene in thyroid neoplastic transformation
48. Direct detection of novel expanded trinucleotide repeats in the human genome
49. Familial adenomatous polyposis-associated thyroid cancer: A clinical, pathological, and molecular genetics study
50. Familial papillary carcinoma of the thyroid
51. Thyroid carcinoma: Current controversies
52. Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families